147 related articles for article (PubMed ID: 5084818)
1. Activation of arginine and tyrosine esterase in serum from patients with hereditary angio-oedema.
Eisen V; Loveday C
Br J Pharmacol; 1972 Sep; 46(1):157-66. PubMed ID: 5084818
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro.
Donaldson VH
J Exp Med; 1968 Mar; 127(3):411-29. PubMed ID: 5299945
[TBL] [Abstract][Full Text] [Related]
3. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
Kaplan AP; Joseph K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
[TBL] [Abstract][Full Text] [Related]
4. In vitro activation of C1s in plasma of patients with hereditary angioneurotic oedema.
Shafiasghar S; Cormane RH; Pondman KW
Clin Exp Immunol; 1976 Aug; 25(2):244-55. PubMed ID: 821682
[TBL] [Abstract][Full Text] [Related]
5. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
Harpel PC
J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
[TBL] [Abstract][Full Text] [Related]
6. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.
Colman RW; Mattler L; Sherry S
J Clin Invest; 1969 Jan; 48(1):23-32. PubMed ID: 4237065
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
8. The plasma bradykinin-forming pathways and its interrelationships with complement.
Kaplan AP; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
[TBL] [Abstract][Full Text] [Related]
9. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
10. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
[TBL] [Abstract][Full Text] [Related]
11. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
[TBL] [Abstract][Full Text] [Related]
12. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema.
Rosen FS; Alper CA; Pensky J; Klemperer MR; Donaldson VH
J Clin Invest; 1971 Oct; 50(10):2143-9. PubMed ID: 4107267
[TBL] [Abstract][Full Text] [Related]
13. Hereditary angioneurotic oedema and blood-coagulation: interaction between C1-esterase-inhibitor and the activation factors of the proteolytic enzyme systems.
Witzke G; Bork K; Benes P; Böckers M
Klin Wochenschr; 1983 Nov; 61(22):1131-5. PubMed ID: 6361369
[TBL] [Abstract][Full Text] [Related]
14. New insights into hereditary angio-oedema: Molecular diagnosis and therapy.
Nagy N; Grattan CE; McGrath JA
Australas J Dermatol; 2010 Aug; 51(3):157-62. PubMed ID: 20695852
[TBL] [Abstract][Full Text] [Related]
15. Inherited high serum levels of a functionally deficient complement esterase inhibitor associated with hereditary angioedema.
Kueppers F; Berendes U; Schöpf E
Humangenetik; 1972; 15(2):119-25. PubMed ID: 4626030
[No Abstract] [Full Text] [Related]
16. The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states.
Colman RW; Mason JW; Sherry S
Ann Intern Med; 1969 Oct; 71(4):763-73. PubMed ID: 5360288
[No Abstract] [Full Text] [Related]
17. Observations on the plasma kallikreinogen (prekallikrein)-kallikrein enzyme system.
Sherry S; Colman RW
Trans Assoc Am Physicians; 1968; 81():40-8. PubMed ID: 5305252
[No Abstract] [Full Text] [Related]
18. [New preparation method of C1 esterase for the dosage of its plasma inhibitor].
Gozin D; Ollier-Hartmann MP; Lerable J; Hartmann L; Soulier JP
Biomed Pharmacother; 1983; 37(5):228-30. PubMed ID: 6607074
[TBL] [Abstract][Full Text] [Related]
19. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
Derkx FH; Bouma BN; Schalekamp MA
J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
[TBL] [Abstract][Full Text] [Related]
20. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
Goldsmith GH; Stern RC; Saito H; Ratnoff OD
J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
